XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (72,040) $ (63,933)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 88 58
Unrealized foreign currency loss 712 4,217
Stock-based compensation 5,464 6,043
Changes in operating assets and liabilities:    
Other current assets and prepaid expenses 3,881 2,061
Accounts payable (951) 1,151
Accrued expenses 5,961 465
Other liabilities 84 (102)
Net cash used in operating activities (56,801) (50,040)
Cash flows from investing activities:    
Purchases of property and equipment (169) (113)
Sale of investments - Other 9,796 0
Net cash provided by (used in) investing activities 9,627 (113)
Cash flows from financing activities:    
Proceeds from public offering of common stock through At The Market offering, net of issuance costs of $9 and $1,226, respectively 282 39,584
Proceeds from exercise of stock options 0 5
Proceeds from the exercise of pre-funded warrants 51 0
Proceeds from shares issued in connection with the Company's employee stock purchase plan 96 130
Net cash provided by financing activities 429 39,719
Effect of exchange rate changes on cash and cash equivalents (311) (3,658)
Net change in cash and cash equivalents (47,056) (14,092)
Cash and cash equivalents, beginning of period 106,745 86,863
Cash and cash equivalents, end of period 59,689 72,771
Supplemental disclosure of noncash investing and financing activities:    
Operating lease right-of use asset obtained in exchange for lease obligation $ 544 $ 0